2006
DOI: 10.1182/blood-2005-03-0897
|View full text |Cite
|
Sign up to set email alerts
|

Gene expression and angiotropism in primary CNS lymphoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

7
179
3
1

Year Published

2006
2006
2014
2014

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 192 publications
(190 citation statements)
references
References 41 publications
7
179
3
1
Order By: Relevance
“…Although of high clinical interest, a correlation of these subgroups with prognosis is hampered by the still limited number of PCNSL available for gene expression profiling and awaits further studies. These data are in accordance with recent observations in a series of 23 PCNSL, 14 which were equally represented in the two histogenetic and the unclassifiable subgroups of DLBCL as defined by gene expression profiling. 16 Thus, our results further support the notion that PCNSL exhibit characteristics associated with both ABC (IGM expression with absence of IG class switch, high frequency of somatic mutations of IG genes, recurrent 18q21 gains, activation of the nuclear factor-kB (NF-kB) pathway, high expression of BCL2 mRNA and protein 1,[17][18][19] ) and GCB type (expression of BCL6, ongoing somatic hypermutation 1,20 ) DLBCL.…”
Section: Discussionsupporting
confidence: 80%
See 2 more Smart Citations
“…Although of high clinical interest, a correlation of these subgroups with prognosis is hampered by the still limited number of PCNSL available for gene expression profiling and awaits further studies. These data are in accordance with recent observations in a series of 23 PCNSL, 14 which were equally represented in the two histogenetic and the unclassifiable subgroups of DLBCL as defined by gene expression profiling. 16 Thus, our results further support the notion that PCNSL exhibit characteristics associated with both ABC (IGM expression with absence of IG class switch, high frequency of somatic mutations of IG genes, recurrent 18q21 gains, activation of the nuclear factor-kB (NF-kB) pathway, high expression of BCL2 mRNA and protein 1,[17][18][19] ) and GCB type (expression of BCL6, ongoing somatic hypermutation 1,20 ) DLBCL.…”
Section: Discussionsupporting
confidence: 80%
“…A CNS-specific impact may also account at least in part for differences in the gene expression pattern between PCNSL and systemic DLBCL as reported by Rubenstein et al 14 These authors observed more than 460 ESTs to be significantly differently expressed between 23 PCNSL and 9 DLBCL and published a list of 29 ESTs to be most differentially expressed between these two lymphoma entities. In these analyses, genes highly expressed in CNS tissue have been excluded in a different way.…”
Section: Discussionmentioning
confidence: 77%
See 1 more Smart Citation
“…27 Some studies have suggested that patients who harbor such abnormalities have a shorter overall survival. 23,25 In our study, despite the apparent trend toward shorter survival in these patients, the difference was not statistically significant. The lack of statistical significance may be related to the small number of our patient sample.…”
Section: Discussioncontrasting
confidence: 74%
“…[23][24][25] Interestingly, both in our study and in earlier reports, the majority of primary central nervous system lymphomas show strong expression of Bcl-2 and C-MYC, indicating that overexpression at protein and mRNA levels is poorly correlated with the rearrangements of BCL2 and C-MYC genes. 25,26 Thirty-three percent (7/21) of cases showed additional signals for IGH, BCL2, and C-MYC. These most likely represent additional gene copies due to trisomy or tetrasomy; however, the rearrangement to an unknown partner cannot be entirely excluded.…”
Section: Discussionsupporting
confidence: 58%